Smart MCs will be represented at BIO-Europe 2026, taking place from 9–11 November 2026 at Koelnmesse in Cologne, Germany. With the support of the Australian Trade and Investment Commission (Austrade) and Investment NSW, we will be joining the Australian delegation at Australia Stand #7-32, connecting with biotechnology and pharmaceutical companies, researchers, and industry partners [...]
Smart MCs CEO and Co-Founder, Dr Payar Radfar, has been invited to deliver a seminar at the Institute of Molecular and Cell Biology (IMCB), part of Singapore's Agency for Science, Technology and Research (A*STAR), on 22 October 2026. The seminar, titled “Innovations in Biomaterials and Microfluidics for Scalable Cell Culture and Tissue Engineering”, will [...]
Smart MCs was pleased to participate in BioJapan 2026, held from 7–9 October at PACIFICO Yokohama, Japan, as part of the Australian Pavilion, Booth D-95. Representing Smart MCs were Dr Payar Radfar, CEO and Co-Founder, and Daisy Jane Toting, Scientific Lead, who attended the three-day event to showcase the company's biomaterial [...]
“How do I know if this microcarrier is actually right for my cells?” Choosing a microcarrier is often treated as a logistical or purchasing decision. In practice, it is a biological decision that directly shapes how cells behave from the moment they encounter a surface. When the microcarrier choice is not well aligned with [...]
We are pleased to announce our partnership with Cell Culture Collective, Inc., who now serves as an official U.S. distributor of Smart MCs products. Through this partnership, researchers and organisations across the United States will have easier access to our smart microcarriers, hydrogels, microfluidics, and laboratory consumables for cell culture, bioprocessing, tissue engineering, and [...]
Figure 1. Overview of the peptide-functionalised hyaluronic acid microcarrier platform developed by Nie et al. Extracellular vesicles (EVs) derived from hepatocyte growth factor (HGF)-engineered mesenchymal stromal cells (MSCs) were captured using CP05-functionalised hyaluronic acid methacrylate (HAMA) microcarriers and evaluated as a sustained delivery platform for diabetic wound healing. Microcarriers are widely used [...]
Figure 1. Overview of PEGDA-based magnetic hydrogel microcarrier fabrication and applications, including microfluidic bead generation, magnetic particle incorporation, UV photopolymerisation, homogeneous and Janus-type microcarrier formats, tunable degradation influenced by temperature and pH, and potential applications in soft robotics, 3D cell culture, cell transport, and drug delivery. Microcarriers are often described as small [...]
Figure 1. Uneven early cell attachment on microcarriers. Microscopy image showing variable cell attachment across microcarriers during the early seeding phase. Some carriers show visible cell attachment, while others remain sparsely populated, illustrating how early seeding conditions can affect attachment consistency. Poor cell attachment is one of the most frustrating issues in [...]
“Why is microcarrier dissolution taking longer than expected?” Microcarrier dissolution is a key step during harvest, but delays are usually linked to how the process is handled. In our experience, when the workflow is well understood and the steps are followed properly, dissolution is straightforward. When something isn’t quite right, or the process is [...]
How the FDA’s roadmap is translating into real regulatory change In April 2026, the U.S. Food and Drug Administration (FDA) released a one-year progress update on its Roadmap to Reducing Animal Testing in Preclinical Safety Studies. The report highlights how early policy commitments are now being implemented across drug development, signalling a broader shift [...]
